Kimberly Dow, NP
Psychiatry · Burlingame
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 15
- 2 carriers
- Office
- 1
- Since medical school
- 6 years
- Vanderbilt University School of Medicine, 2020
Offices
1 location · Mindful Health Solutions A Professional Medical Corporation · 55 clinicians in this group
Looking this up.
Plans that list them
15 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Kimberly Dow’s office at (844) 867-8444 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
15 of 15 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Drugs they prescribed that Part D paid
$7,286
Pharmacies billed $7,286 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 136) in 2024. At or below the middle of the specialty; the typical psychiatry clinician is at 0%.
131 generic and fewer than 11 brand-name prescriptions · $7,286 in drug cost · 12 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Clonazepam | 26 | $127 | $5 |
| Duloxetine | 11 | $81 | $7 |
| Lorazepam | 13 | $63 | $5 |
Year by year
| 2024 | 136 | 18 | 0% (0) | None | $7,286 |
| 2023 | 77 | 17 | 0% (0) | None | $13,425 |
| 2022 | 108 | 27 | 0% (0) | None | $5,852 |
| 2021 | 164 | 36 | 0% (0) | None | $9,486 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Clonazepam | 11 | $84 | $8 |
2022: 2 drugs
| Mirtazapine | 18 | $1,760 | $98 |
| Sertraline | 21 | $168 | $8 |
2021: 5 drugs
| Mirtazapine | 20 | $1,742 | $87 |
| Sertraline | 40 | $265 | $7 |
| Escitalopram | 17 | $162 | $10 |
| Citalopram Hbr | 13 | $83 | $6 |
| Diazepam | 13 | $48 | $4 |
Money from drug and device companies
$364 in 2025
| 2025 | 8 | 14 | None | $364 |
| 2024 | 8 | 22 | None | $548 |
| 2023 | 9 | 25 | None | $693 |
| 2022 | 2 | 2 | None | $148 |
| 2021 | 1 | 1 | None | $125 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Vraylar | $94 | 4 payments
|
| Vanda Pharmaceuticals | Fanapt | $92 | 3 payments
|
| Axsome Therapeutics | Auvelity | $53 | 2 payments
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $30 | 1 payment
|
| Janssen Pharmaceuticals | Spravato | $29 | 1 payment
|
| Lundbeck | Rexulti | $26 | 1 payment
|
See all 14 published payments
| Abbvie | Meals · 2025-12-10 | Vraylar | $23 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-11-05 | Cobenfy | $16 |
| Axsome Therapeutics | Meals · 2025-11-04 | Auvelity | $27 |
| Abbvie | Meals · 2025-10-07 | Vraylar | $24 |
| Axsome Therapeutics | Meals · 2025-08-12 | Auvelity | $26 |
| Tris Pharma | Meals · 2025-07-11 | Dyanavel Xr | $23 |
| Vanda Pharmaceuticals | Meals · 2025-07-09 | Fanapt | $33 |
| Abbvie | Meals · 2025-06-11 | Vraylar | $21 |
| Janssen Pharmaceuticals | Meals · 2025-05-29 | Spravato | $29 |
| Vanda Pharmaceuticals | Meals · 2025-05-22 | Fanapt | $27 |
| Vanda Pharmaceuticals | Meals · 2025-05-15 | Fanapt | $32 |
| Lundbeck | Meals · 2025-05-08 | Rexulti | $26 |
| Abbvie | Meals · 2025-04-22 | Vraylar | $26 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-04-02 | Caplyta | $30 |
See earlier years (2024, 2023, 2022, 2021)
2024: $548
| Lundbeck | Rexulti | $221 | 8 payments
|
| Janssen Pharmaceuticals | Spravato | $133 | 6 payments
|
| Noven Therapeutics | Secuado | $42 | 2 payments
|
| Abbvie | Vraylar | $40 | 2 payments
|
| Neurocrine Biosciences | Ingrezza | $32 | 1 payment
|
| Tris Pharma | Dyanavel Xr | $30 | 1 payment
|
| Axsome Therapeutics | Auvelity | $28 | 1 payment
|
| Otsuka America Pharmaceutical | Rexulti | $21 | 1 payment
|
2023: $693
| Abbvie | Vraylar | $334 | 11 payments
|
| Iti | Caplyta | $102 | 3 payments
|
| Vanda Pharmaceuticals | Hetlioz | $81 | 3 payments
|
| Neurocrine BioSciences | Ingrezza | $59 | 2 payments
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $38 | 2 payments
|
| Alkermes | Aristada | $24 | 1 payment
|
| Bausch Health US | Aplenzin | $20 | 1 payment
|
| Otsuka America Pharmaceutical | Abilify Maintena | $20 | 1 payment
|
| Lundbeck | Rexulti | $15 | 1 payment
|
2022: $148
| Tris Pharma | Quillivant | $124 | 1 payment
|
| Corium | Azstarys | $24 | 1 payment
|
2021: $125
| Alkermes | Aristada | $125 | 1 payment
|
Professional record
- NPI
- 1316486541
- Licence
- CA 95020721, MA 120808, MA 221100, MA RN2342534
- Trained
- Vanderbilt University School of Medicine, 2020 · 6 years ago
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LP0808X (363LP0808X); Federal specialty code 1041C0700X (1041C0700X); Federal specialty code 172V00000X (172V00000X)
- Mailing address
- 1860 El Camino Real Ste 250, Burlingame, CA, 94010
- NPI first listed
- 2017-02-21
- NPI last updated
- 2022-06-08
- NPI record certified
- 2022-05-20
This is when the NPI record was last certified, not a medical board exam.